(Q40303946)

19 September 2017

title

Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine (English)

1 reference

19 September 2017

0 references

Riccardo N Caniato

1

1 reference

19 September 2017

Marlies E Alvarenga

series ordinal

2

1 reference

19 September 2017

Miguel Angel Garcia-Alcaraz

series ordinal

3

1 reference

19 September 2017

publication date

1 August 2006

1 reference

Australian and New Zealand Journal of Psychiatry

19 September 2017

published in

1 reference

19 September 2017

volume

40

1 reference

19 September 2017

issue

8

1 reference

19 September 2017

page(s)

691-697

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

19 September 2017

1 reference

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

Dietary carbohydrates and triacylglycerol metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

Beyond the Mediterranean diet: the role of omega-3 Fatty acids in the prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

Hypertriglyceridemia as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2006.01869.X

10.1111/J.1440-1614.2006.01869.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference